ArticleCureus2025
The Efficacy of Ambulatory Blood Pressure Monitoring-Derived Indices in Predicting Organ Damage in Patients With Hypertension.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Investigation Patterns and the Apparent Epidemiology of Hypertension-Mediated Organ Damage.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Diagnostic Testing Patterns Influence the Detected Burden of Hypertension-Mediated Organ Damage in Hospitalized Hypertensive Patients.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Albuminuria as a Key Factor Associated with Ambulatory Arterial Stiffness: A Hierarchical Multivariable Analysis.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Hypertension (HT)-mediated organ damage (HMOD) refers to structural or functional damage in organs caused by chronic HT, which plays a critical role in determining cardiovascular mortality risk. Traditional ambulatory blood pressure monitoring (ABPM) parameters have limited utility in predicting its occurrence. To address this gap, we focused on indices that reflect blood pressure (BP) variability and arterial stiffness, such as average real variability (ARV), ambulatory arterial stiffness index (AASI), and pulse pressure index (PPI). This study aimed to examine the ability of these novel ABPM-derived indices to enhance the prediction of HMOD. Methods Seventy-nine hypertensive patients were assessed for end-organ damage in the heart, retina, and kidneys. Cardiac involvement was evaluated using echocardiography, focusing on left ventricular mass index (LVMI), relative wall thickness, and diastolic function. Patients with left ventricular hypertrophy (LVH) or diastolic dysfunction were considered to have hypertensive cardiomyopathy. Retinal damage was assessed via fundoscopic examinations, identifying changes like hemorrhages and arterial narrowing. Renal involvement was determined based on the estimated glomerular filtration rate (<60 mL/min/1.73 m²) and albuminuria (>30 mg/g). Patients were classified into HMOD and non-HMOD groups based on these criteria. ABPM was conducted to measure traditional parameters, such as 24-hour systolic BP (SBP) and diastolic BP (DBP), and novel indices like ARV, AASI, and PPI. Regression analysis, including demographic characteristics such as age and gender, was also used to evaluate the independent predictive value of ARV, AASI, and PPI. Results Traditional ABPM parameters, including 24-hour BP, did not significantly differ between patients with and without HMOD. However, novel indices such as ARV, AASI, and PPI were significantly higher in the HMOD group and showed stronger predictive value. ARV (OR: 2.026, 95% CI: 1.294-3.171, p=0.002), AASI (OR: 4.950, 95% CI: 1.840-13.317, p=0.002), and PPI (OR: 1.209, 95% CI: 1.081-1.352, p=0.001) emerged as independent predictors of HMOD. Conclusions ARV, AASI, and PPI were found to independently predict HMOD, providing a useful tool for better risk assessment in hypertensive patients. These results suggest that novel ABPM indices could improve early detection and management of HMOD. Further research involving larger and more diverse populations is needed to confirm these findings and guide clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.